Carregant...
Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma
The treatment paradigm for advanced and metastatic renal cell carcinoma (mRCC) has evolved rapidly since the arrival of targeted therapies and novel immunotherapies. mRCC was previously treated only with cytokines. However, discoveries of mutations affecting the von Hippel-Lindau tumor suppressor ge...
Guardat en:
| Publicat a: | Am Soc Clin Oncol Educ Book |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855178/ https://ncbi.nlm.nih.gov/pubmed/28561652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_174469 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|